compass_positive_tagline-01.png
COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
September 14, 2021 07:00 ET | COMPASS Pathfinder Ltd.
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it has acquired an...
compass_positive_tagline-01.png
Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds
September 10, 2021 07:00 ET | COMPASS Pathfinder Ltd.
      COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has engaged Hamilton Morris,...
compass_positive_tagline-01.png
Guy Goodwin joins COMPASS Pathways as Chief Medical Officer
July 29, 2021 08:30 ET | COMPASS Pathfinder Ltd.
COMPASS announces changes to its Executive Team London, UK – 29 July 2021         COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating...
compass_positive_tagline-01.png
Danielle Schlosser joins COMPASS Pathways from Verily Life Sciences to lead clinical innovation and therapist training
July 21, 2021 07:00 ET | COMPASS Pathfinder Ltd.
      London, UK – 21 July 2021         COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
compass_positive_tagline-01.png
COMPASS Pathways to participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit
July 07, 2021 07:00 ET | COMPASS Pathfinder Ltd.
London, UK, July 07, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
compass_positive_tagline-01.png
COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK
July 05, 2021 06:00 ET | COMPASS Pathfinder Ltd.
London, UK – 5 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”
June 30, 2021 07:00 ET | COMPASS Pathfinder Ltd.
      London, UK – 30 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
compass_positive_tagline-01.png
COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme
June 23, 2021 07:00 ET | COMPASS Pathfinder Ltd.
Programme aims to support students from under-represented ethnic groups London, UK – 23 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
compass_positive_tagline-01.png
COMPASS Pathways announces pricing of public offering
April 29, 2021 20:45 ET | COMPASS Pathfinder Ltd.
      London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based...
compass_positive_tagline-01.png
COMPASS Pathways launches proposed public offering
April 27, 2021 17:22 ET | COMPASS Pathfinder Ltd.
London, UK, April 27, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...